The Indonesian Food and Drug Authority (BPOM) is calling for a global shift in laboratory standards and interconnectivity to address the emerging health risks posed by microplastics and nanoplastics. BPOM Chairman Taruna Ikrar stated on Monday that current international regulatory frameworks lack the necessary safety standards to manage these particles, which may be linked to cardiovascular damage and other ischemic diseases.
The Link Between Microplastics and Vascular Health
Research published in The New England Journal of Medicine suggests a possible connection between microplastics and atherosclerosis, a condition characterized by plaque buildup in the arteries. According to Ikrar, the concern centers on how these materials infiltrate the human vascular system.
While the exact mechanism remains under investigation, Ikrar noted that nanoparticles derived from microplastics may enter the bloodstream and damage the endothelial system. This potential systemic damage could increase the risk of serious health conditions, including stroke.
Did You Know?
BPOM has initiated partnerships with the World Health Organization (WHO) and the Asian Development Bank (ADB) specifically to improve laboratory quality and testing capabilities within Indonesia.
Why Global Laboratory Standards Matter
The absence of internationally recognized safety standards for microplastics in consumer products creates a significant regulatory gap. BPOM is currently engaging with the House of Representatives to emphasize that high-quality laboratory capacity is essential to defining acceptable exposure levels.
Ikrar highlighted that this need for rigorous testing extends beyond microplastics to the broader regulation of medicines and illegal drugs. He argued that government, university, and industrial laboratories must all adhere to high-quality standards to ensure the safety, efficacy, and quality of products reaching the public.
What May Happen Next
As regulatory bodies like BPOM continue to coordinate with international partners, the development of standardized testing procedures for consumer goods is a possible next step. Domestically, the integration of higher testing standards across Indonesian sectors—including industry and academia—is likely to become a priority to enhance patient safety and product compliance.
Frequently Asked Questions
What health risk is associated with microplastics according to BPOM?
BPOM Chairman Taruna Ikrar cited a study in The New England Journal of Medicine that identifies a possible link between microplastics and atherosclerosis, which could potentially increase the risk of ischemic diseases such as stroke.
Why is BPOM calling for global laboratory interconnectivity
